首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   78594篇
  免费   6029篇
  国内免费   4108篇
耳鼻咽喉   1999篇
儿科学   559篇
妇产科学   2361篇
基础医学   4378篇
口腔科学   527篇
临床医学   9216篇
内科学   5768篇
皮肤病学   343篇
神经病学   649篇
特种医学   4808篇
外国民族医学   56篇
外科学   15235篇
综合类   14207篇
现状与发展   3篇
预防医学   2040篇
眼科学   233篇
药学   3391篇
  14篇
中国医学   1179篇
肿瘤学   21765篇
  2024年   185篇
  2023年   760篇
  2022年   1691篇
  2021年   2127篇
  2020年   2028篇
  2019年   1697篇
  2018年   1528篇
  2017年   1970篇
  2016年   2663篇
  2015年   2240篇
  2014年   4469篇
  2013年   3877篇
  2012年   5052篇
  2011年   5602篇
  2010年   4913篇
  2009年   4710篇
  2008年   4647篇
  2007年   5174篇
  2006年   4875篇
  2005年   4767篇
  2004年   3740篇
  2003年   3288篇
  2002年   2831篇
  2001年   2698篇
  2000年   2217篇
  1999年   1695篇
  1998年   1427篇
  1997年   1270篇
  1996年   782篇
  1995年   684篇
  1994年   588篇
  1993年   357篇
  1992年   333篇
  1991年   268篇
  1990年   254篇
  1989年   238篇
  1988年   213篇
  1987年   183篇
  1986年   158篇
  1985年   114篇
  1984年   81篇
  1983年   47篇
  1982年   69篇
  1981年   51篇
  1980年   49篇
  1979年   33篇
  1978年   26篇
  1977年   27篇
  1976年   13篇
  1975年   10篇
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
71.
在体外培养瘤细胞的实验中,胰RNA提取物对艾氏腹水瘤细胞及其他瘤细胞(S_(180),P_(88),H_(22))有杀伤作用。在胰RNA提取物中,对瘤细胞具有杀伤作用的活性物质不是性凝集素样多糖类物质或能透过半透膜的小分子化合物,而是具有二级结构的低分子RNA。  相似文献   
72.
顺铂对结直肠癌肿瘤浸润淋巴细胞杀伤活性的影响   总被引:1,自引:0,他引:1  
为在临床选择有效的免疫化疗方案提供一定的理论依据,作者以结直肠癌肿瘤浸润淋巴细胞(TIL)和顺铂(CDDP)为研究对象,对16名手术治疗的结直肠癌患者,分别观察CDDP体内注射及体外预处理TIL和Raji细胞对TIL表面标志和杀伤活性的影响。流式细胞仪检测结果显示,静脉注射CDDP能增加结直肠癌TIL中CD3+/CD4+和CD3+/CD8+细胞含量,同时增强TIL体外杀伤Raji细胞的活性;而体外以CDDP处理Raji细胞能增强其对结直肠癌TIL杀伤的敏感性。作者认为,对于联合应用TIL和CDDP治疗结直肠癌的临床效果有必要进一步研究。  相似文献   
73.
BTA在膀胱癌诊断中的应用   总被引:2,自引:1,他引:1  
为了探求对膀胱肿瘤诊断及术后复发监测的理想手段,从1995年9月~1996年6月,采用BTA试剂检测方法对202例血尿患者及71例膀胱肿瘤术后的患者进行了诊断检测,诊断膀胱癌的敏感度为96%、特异度为83%、准确度为86%,26例膀胱肿瘤患者中仅6例(23%)尿脱落细胞阳性,正常对照均为阴性。认为BTA试剂是一种快速、有效、无创性诊断膀胱肿瘤的方法。  相似文献   
74.
This study compares liver lesion detection, characterization, and effect on patient management between single-phase spiral CT and MRI using spoiled gradient echo (SGE), T2-weighted fat-suppressed spin echo, and serial post gadolinium SGE. All patients with suspected liver lesions who underwent spiral CT and MRI within a 1-month period between January 1993 and September 1996 were included in the study. Spiral CT and MRI were interpreted prospectively in a blinded fashion by separate individual experienced investigators, and lesion detection and characterization were determined. Confirmation was obtained by surgery (6 patients), biopsy (18 patients), imaging follow-up (36 patients), or combined reading of all imaging studies and clinical follow-up (29 patients). Effect on patient management was determined by combined chart review and interview of the patients' physicians and by retrospective clinical assessment performed by a surgical oncologist and medical oncologist separately. Eighty-nine patients were included in the study. Regarding true positive lesion detection, 295 and 519 lesions were detected on spiral CT and MR images, respectively, which was significantly different on a patient-by-patient basis (P < .001). More lesions were detected on MR than on spiral CT in 44 of 89 patients (49.4%), and 11 of these 44 patients had lesions shown on MRI in whom no lesions were apparent on CT images. No patients had true positive lesions shown on spiral CT that were not shown on MRI. Regarding lesion characterization, 129 and 466 lesions were characterized on spiral CT and MRI images, respectively, which was significantly different on a patient-by-patient basis (P < .001). More lesions were characterized on MR than CT images in 67 patients (75.3%). Regarding effect on patient management, chart review with physician interview demonstrated that findings on MRI provided information that altered patient management as compared with findings on spiral CT in 57 patients. Retrospective clinical evaluation by the surgical and medical oncologist showed that MRI was considered to have a greater effect on patient management than spiral CT in 58 and 55 patients, respectively. Comparing current MRI technique to single-phase spiral CT, MRI detected more lesions in 49.4% and characterized more lesions in 75.3% of patients investigated for focal liver disease. MRI had a greater effect on patient management in each of the three methods than singlephase spiral CT in more than 61% of patients.  相似文献   
75.
76.
77.
78.
We report a patient with metastatic thyroid carcinoma invading the esophagus in whom barium and MR examinations revealed an expansile intraluminal mass indistinguishable from that of a primary esophageal malignancy. Metastatic thyroid carcinoma should therefore be included in the differential diagnosis of an expansile esophageal mass. As in our patient, MR imaging may be useful for showing that the mass originates in the thyroid gland.  相似文献   
79.
This study compares the efficacy of omeprazole and ranitidine at reducing gastric secretion in obstetric patients. Sixty-five women scheduled to undergo elective Caesarean section under general anaesthesia were randomly allocated to receive either omeprazole 40 mg or ranitidine 150 mg orally at 2200 hours the night before and at 0600 hours on the morning of surgery. Intragastric pH and volume were measured immediately after induction of anaesthesia and on completion of surgery. All patients had gastric aspirates less than 25 ml. None of the omeprazole group had an aspirate of pH less than 3.5. Six patients (19%) in the ranitidine group had aspirates of pH less than 3.5, a significant difference from the omeprazole group (p less than 0.05). Of these six, two (6%) had aspirates of pH less than 2.5. Hence this study showed that omeprazole was more effective and consistent than ranitidine at maintaining gastric pH greater than 3.5.  相似文献   
80.
改良Indiana膀胱术的远期疗效观察   总被引:1,自引:1,他引:0  
目的:评价改良Indiana膀胱术的远期疗效.方法:对26例改良Indiana膀胱术术后患者的膀胱可控性、尿动力学、肾盂输尿管扩张、上尿路感染情况、血清电解质和肾功能进行随访.结果:26例随访1~7年,平均3年.白天可控率96.2%;贮尿囊容量为380~640 ml,平均542 ml;贮尿囊内压力为1.215~3.224 kPa,平均1.921 kPa.B超、IVP造影示3 例输尿管扩张,经随访无加重.血清电解质及肾功能正常.结论:改良Indiana膀胱术远期疗效可靠,并发症少,是一种较理想的尿路分流术式.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号